BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 26908193)

  • 1. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki KI; Arai Y; Yamashita Y; Yamamoto K; Sakuma Y; Oridate N
    Int J Clin Oncol; 2016 Oct; 21(5):869-874. PubMed ID: 26908193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.
    Yom SS; Machtay M; Biel MA; Sinard RJ; El-Naggar AK; Weber RS; Rosenthal DI
    Am J Clin Oncol; 2005 Aug; 28(4):385-92. PubMed ID: 16062081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.
    Akbaba S; Held T; Lang K; Hoerner-Rieber J; Zaoui K; Forster T; Rieken S; Plinkert P; Debus J; Adeberg S
    Radiat Oncol; 2019 Feb; 14(1):34. PubMed ID: 30782197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
    Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment results and prognostic factors for advanced squamous cell carcinoma of the hypopharynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Yabuki K; Arai Y; Takahashi H; Hata M; Koike I; Oridate N
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1147-54. PubMed ID: 24658628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
    Cmelak AJ; Li S; Goldwasser MA; Murphy B; Cannon M; Pinto H; Rosenthal DI; Gillison M; Forastiere AA
    J Clin Oncol; 2007 Sep; 25(25):3971-7. PubMed ID: 17761982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
    Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
    Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx.
    Iizuka Y; Yoshimura M; Inokuchi H; Matsuo Y; Nakamura A; Mizowaki T; Hirano S; Kitamura M; Tateya I; Hiraoka M
    Acta Otolaryngol; 2015 Jan; 135(1):96-102. PubMed ID: 25351439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage surgery for local residual or recurrent pharyngeal cancer after radiotherapy or chemoradiotherapy.
    Omura G; Saito Y; Ando M; Kobayashi K; Ebihara Y; Yamasoba T; Asakage T
    Laryngoscope; 2014 Sep; 124(9):2075-80. PubMed ID: 24676876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experience.
    Lavertu P; Adelstein DJ; Saxton JP; Secic M; Eliachar I; Strome M; Larto MA; Wood BG
    Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):142-8. PubMed ID: 10037279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma.
    Suzuki K; Hayashi R; Ebihara M; Miyazaki M; Shinozaki T; Daiko H; Sakuraba M; Zenda S; Tahara M; Fujii S
    Jpn J Clin Oncol; 2013 Dec; 43(12):1210-7. PubMed ID: 24031082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of salvage surgery for recurrent or residual head and neck squamous cell carcinoma.
    Maruo T; Zenda S; Shinozaki T; Tomioka T; Okano W; Sakuraba M; Tahara M; Hayashi R
    Jpn J Clin Oncol; 2020 Mar; 50(3):288-295. PubMed ID: 31845736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer.
    Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Int J Clin Oncol; 2015 Dec; 20(6):1081-5. PubMed ID: 25804347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive radiotherapy for T1-2 hypopharyngeal cancer: a single-institution experience.
    Nakajima A; Nishiyama K; Morimoto M; Nakamura S; Suzuki O; Kawaguchi Y; Miyagi K; Fujii T; Yoshino K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e129-35. PubMed ID: 21640496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review.
    Putten L; Bree R; Doornaert PA; Buter J; Eerenstein SE; Rietveld DH; Kuik DJ; Leemans CR
    Acta Otorhinolaryngol Ital; 2015 Jun; 35(3):162-72. PubMed ID: 26246660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative complications after en bloc salvage surgery for head and neck cancer.
    Agra IM; Carvalho AL; Pontes E; Campos OD; Ulbrich FS; Magrin J; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1317-21. PubMed ID: 14676158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
    León X; Agüero A; López M; García J; Farré N; López-Pousa A; Quer M
    Auris Nasus Larynx; 2015 Apr; 42(2):145-9. PubMed ID: 25459494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.